University of Utah
Salt Lake City
I am a Professor of Medicine and Chief, Division of Rheumatology, Department of Medicine , Spencer Fox Eccles School of Medicine , University of Utah. I am a clinical Rheumatologist involved in translational research focused on gout diagnosis, pathology, and treatment.
10F104: Rheumatic Disease in Indigenous Populations
Friday, November 10, 2023
12:00 PM – 1:00 PM PT
Disclosure(s): ANI: Advisor or Review Panel Member (Terminated); Arthosi: Advisor or Review Panel Member (Ongoing); Horizon: Advisor or Review Panel Member (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); Olatec: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Protalix: Advisor or Review Panel Member (Ongoing); Shanton: Advisor or Review Panel Member (Ongoing); SOBI: Advisor or Review Panel Member (Terminated)
Rheumatic Disease in Indigenous Populations Introductions
Friday, November 10, 2023
12:00 PM – 12:05 PM PT
Disclosure(s): ANI: Advisor or Review Panel Member (Terminated); Arthosi: Advisor or Review Panel Member (Ongoing); Horizon: Advisor or Review Panel Member (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); Olatec: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Protalix: Advisor or Review Panel Member (Ongoing); Shanton: Advisor or Review Panel Member (Ongoing); SOBI: Advisor or Review Panel Member (Terminated)
Rheumatic Disease in Indigenous Populations: Panel Discussion
Friday, November 10, 2023
12:35 PM – 1:00 PM PT
Disclosure(s): ANI: Advisor or Review Panel Member (Terminated); Arthosi: Advisor or Review Panel Member (Ongoing); Horizon: Advisor or Review Panel Member (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); Olatec: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Protalix: Advisor or Review Panel Member (Ongoing); Shanton: Advisor or Review Panel Member (Ongoing); SOBI: Advisor or Review Panel Member (Terminated)
Strategies for Optimizing Contemporary Gout Care in Patients with Common Comorbidities
Sunday, November 12, 2023
2:15 PM – 2:30 PM PT
Disclosure(s): ANI: Advisor or Review Panel Member (Terminated); Arthosi: Advisor or Review Panel Member (Ongoing); Horizon: Advisor or Review Panel Member (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); Olatec: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Protalix: Advisor or Review Panel Member (Ongoing); Shanton: Advisor or Review Panel Member (Ongoing); SOBI: Advisor or Review Panel Member (Terminated)
14T140: The Word Is Out: New Mechanisms and Targets of Gout
Tuesday, November 14, 2023
12:00 PM – 1:00 PM PT
Disclosure(s): ANI: Advisor or Review Panel Member (Terminated); Arthosi: Advisor or Review Panel Member (Ongoing); Horizon: Advisor or Review Panel Member (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); Olatec: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Protalix: Advisor or Review Panel Member (Ongoing); Shanton: Advisor or Review Panel Member (Ongoing); SOBI: Advisor or Review Panel Member (Terminated)